Peptidream, Inc. (4587) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Cyfuse Biomedical KK

Peptidream, Inc.

Chiome Bioscience, Inc.

SUSMED, Inc.

StemCell Institute

OncoTherapy Science, Inc.

GNI Group Ltd.

Oncolys BioPharma, Inc.

MEDINET Co., Ltd.

Carna Biosciences, Inc.

Stella Pharma Corp.

Why is Peptidream, Inc. ?

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -39.32%, its profits have fallen by -125%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -39.32% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Peptidream, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Peptidream, Inc.

-39.32%

48.89

46.35%

Japan Nikkei 225

66.43%

2.61

25.49%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

9.66%

EBIT Growth (5y)

-193.42%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

0.75

Net Debt to Equity (avg)

-0.30

Sales to Capital Employed (avg)

0.49

Tax Ratio

28.04%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

36.72%

ROE (avg)

19.37%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.35

EV to EBIT

-32.35

EV to EBITDA

-56.51

EV to Capital Employed

4.04

EV to Sales

8.69

PEG Ratio

Dividend Yield

ROCE (Latest)

-12.47%

ROE (Latest)

-7.28%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -23.09% (YoY

NET SALES(Q)

Highest at JPY 5,663.85 MM

OPERATING PROFIT(Q)

Highest at JPY -392.04 MM

OPERATING PROFIT MARGIN(Q)

Highest at -6.92 %

PRE-TAX PROFIT(Q)

Highest at JPY -982.82 MM

NET PROFIT(Q)

Highest at JPY -531.86 MM

EPS(Q)

Highest at JPY -4.12

-11What is not working for the Company

NET SALES(9M)

At JPY 14,287.99 MM has Grown at -66.34%

NET PROFIT(9M)

At JPY -2,715.82 MM has Grown at -117.13%

OPERATING CASH FLOW(Y)

Lowest at JPY -13,276.88 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 3.75 times

Here's what is working for Peptidream, Inc.

Net Sales

At JPY 5,663.85 MM has Grown at 26.36%

over average net sales of the previous four periods of JPY 4,482.39 MM

MOJO Watch

Near term sales trend is very positive

Net Sales (JPY MM)

Net Sales

Highest at JPY 5,663.85 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (JPY MM)

Operating Profit

Highest at JPY -392.04 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (JPY MM)

Operating Profit Margin

Highest at -6.92 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at JPY -982.82 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (JPY MM)

Net Profit

Highest at JPY -531.86 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (JPY MM)

Net Profit

At JPY -531.86 MM has Grown at 63.46%

over average net sales of the previous four periods of JPY -1,455.74 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (JPY MM)

EPS

Highest at JPY -4.12

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (JPY)

Raw Material Cost

Fallen by -23.09% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Peptidream, Inc.

Operating Cash Flow

Lowest at JPY -13,276.88 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (JPY MM)

Inventory Turnover Ratio

Lowest at 3.75 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio